Search

everythinglearnresearchcommunity

for

Search:↓

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

A young man with an eating disorder had a life-threatening adrenal crisis due to an autoimmune condition, highlighting the need for better education on managing hormone treatments.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Hair absorbs alkali bromide salts and water, affecting its structure, with absorption decreasing at higher temperatures.

COVID-19 doesn't make alopecia areata worse.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

AB+ blood group is more common in alopecia areata patients.

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

New scaffold materials help heal severe skin wounds and improve skin regeneration.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Baricitinib 4 mg should be used for at least 1 year to see significant hair regrowth in severe alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

Lower vitamin D levels are linked to more severe alopecia areata.

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Baricitinib is effective and safe for treating severe alopecia areata.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Monthly PRP therapy is more effective than daily minoxidil for alopecia areata.